Table 1 Details of the clinical cohorts used in this study.
Data source | Tissue type | Normal tissue | Tumor tissue | Prognostic data |
|---|---|---|---|---|
TCGA-LIHC | HCC | 50 | 373 | 373 |
ICGC-JP | HCC | 202 | 240 | 240 |
GSE112790 | HCC | 15 | 183 | NA |
GSE14520 | HCC | 220 | 225 | 221 |
GSE98638 | HCC | NA | 6 | NA |
GSE91061 | Melanoma | NA | 101 | 101 |
GSE100797 | Melanoma | NA | 25 | 25 |
KM Plotter-Nivolumab | NA | NA | 173 | 173 |
KM Plotter-Ipilimumab | NA | NA | 112 | 112 |
